#153871

pROSA26-Puro-iRFP720 CRISPR vector

Please Enter Your Email ID
Email ID

Cat. #153871

pROSA26-Puro-iRFP720 CRISPR vector

Cat. #: 153871

Sub-type: Mammalian expression, CRISPR, shuttle

Availability: 3-5 days

Target: Gt(ROSA)26Sor; ROSA26

Bacterial Resistance: Ampicillin

Selectable Markers: Puromycin

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Dr Andrew Stephens ; Amy Wilson

Institute: Hudson Institute Of Medical Research

Tool Details
Target Details
Application Details

Tool Details

*FOR RESEARCH USE ONLY

  • Tool name: pROSA26-Puro-iRFP720 CRISPR vector
  • Research fields: Genetics
  • Tool sub type: Mammalian expression, CRISPR, shuttle
  • Backbone size without insert: 8018
  • Bacterial resistance: Ampicillin
  • Selectable markers: Puromycin
  • Description: Cancer Research Technology Limited (trading research tools as Ximbio) has been granted a non-exclusive license to the CRISPR-Cas9 technology by ERS Genomics Ltd under the patent rights listed here. This license from ERS Genomics Ltd allows Ximbio to develop and commercialise CRISPR-Cas9 modified cell lines and vectors for research use only. Ximbio can provide these CRISPR-Cas9 research tools to companies under a label-use only license.
  • Additional notes: Cancer Research Technology Limited (trading research tools as CancerTools.org) has been granted a non-exclusive license to the CRISPR-Cas9 technology by ERS Genomics Ltd under the patent rights listed here: https://www.cancertools.org/tool-faqs#hs_cos_wrapper_widget_1649861453796 This license from ERS Genomics Ltd allows CancerTools.org to develop and commercialise CRISPR-Cas9 modified cell lines for research use only. CancerTools.org can provide these modified CRISPR-Cas9 cell lines to companies under a label-use only license
  • Recommended controls: Contains iRFP720 for positive transfection/integration control

Target Details

  • Target: Gt(ROSA)26Sor; ROSA26

Application Details

  • Application notes: Cancer Research Technology Limited (trading research tools as Ximbio) has been granted a non-exclusive license to the CRISPR-Cas9 technology by ERS Genomics Ltd under the patent rights listed here. This license from ERS Genomics Ltd allows Ximbio to develop and commercialise CRISPR-Cas9 modified cell lines and vectors for research use only. Ximbio can provide these CRISPR-Cas9 research tools to companies under a label-use only license.